13.2 NMBI Medication Management Guidance & Controlled Drug Regulations

NMBI Medication Management Guidance & Controlled Drug Regulations

Statutory and Regulatory Foundation: Medication management is an integral component of nursing practice in the Republic of Ireland. The Nursing and Midwifery Board of Ireland (NMBI) Guidance for Registered Nurses and Midwives on Medication Management sets forth the professional and ethical framework under which nurses exercise clinical judgment, practice within their competence, and uphold patient safety. In conjunction with national legislation—notably the Irish Medicinal Products (Prescription and Control of Supply) Regulations and the Misuse of Drugs Regulations 1988/2017—registered nurses bear direct personal accountability for ensuring that every medication administered is legally valid, clinically indicated, safely delivered, and accurately recorded.

---

The 10 Rights of Medication Administration

Modern Irish nursing practice expands traditional safety checks into the 10 Rights of Medication Administration. Registered General Nurses must systematically verify each of these rights before, during, and after medication delivery:

+-----------------------------------------------------------------------------+
|                 THE 10 RIGHTS OF MEDICATION ADMINISTRATION                  |
+-----------------------------------------------------------------------------+
|  1. RIGHT PATIENT      -> Verify 3 identifiers (Name, DOB, MRN) on wristband|
|  2. RIGHT MEDICATION   -> Check generic name, expiry date; 3 label checks   |
|  3. RIGHT DOSE         -> Calculate accurately; independent double checks   |
|  4. RIGHT ROUTE        -> Confirm prescribed enteral/parenteral route       |
|  5. RIGHT TIME         -> Administer within permissible scheduled window    |
|  6. RIGHT REASON       -> Verify clinical indication against patient status |
|  7. RIGHT DOCUMENTATION-> Immediate signature on kardex; record omissions   |
|  8. RIGHT TO REFUSE    -> Respect informed refusal; explain, notify doctor  |
|  9. RIGHT EDUCATION    -> Explain purpose, expected effects, and side effects|
| 10. RIGHT EVALUATION   -> Monitor therapeutic response and adverse events   |
+-----------------------------------------------------------------------------+

1. Right Patient

• Nurses must verify three distinct patient identifiers:
  1. Patient's full legal name (first name and surname; check for identical names on the ward).
  2. Date of birth (DOB).
  3. Medical Record Number (MRN) or unique hospital identifier.
• Active Identification Technique: The nurse must actively ask the patient: "Could you please tell me your full name and date of birth?" Never ask closed confirmation questions (e.g., "Are you Mr. Murphy?"), which confused or hearing-impaired patients may affirm inappropriately.
• Match the verbal response directly against the patient's identification wristband and the Medication Kardex. In non-communicative or unconscious patients, two nurses must cross-check the wristband against the kardex.
• Crucial Rule: Never use the patient's room number or bed number as an identifier. Beds and rooms change frequently.

2. Right Medication

• Check the generic (non-proprietary) drug name against the prescriber's order. Brand names may only be used when biological comparability requires it (e.g., biosimilars, certain antiepileptics, or specific insulin brands).
• Execute the Three-Check Rule:
  1. Check the medication package when removing it from the pharmacy shelf, ward drawer, or controlled drugs cupboard.
  2. Check the medication label against the kardex while preparing the dose (measuring liquids, expelling blister packs).
  3. Check the medication label against the kardex immediately before administering it to the patient at the bedside.
• Inspect the physical container: confirm intact seals, check clarity/absence of precipitation in ampoules, and verify the expiration date.

3. Right Dose

• Confirm that the prescribed dose is within the standard therapeutic range recommended by the British National Formulary (BNF) or Irish national clinical guidelines.
• Check whether the dose requires weight, age, or renal/hepatic adjustment.
• If a calculation is required (e.g., converting milligrams to millilitres), perform the math explicitly and obtain an independent double check from a second registered nurse for all high-alert medications and pediatric prescriptions.

4. Right Route

• Verify that the prescribed route (oral, sublingual, subcutaneous, intramuscular, intravenous, transdermal, rectal, inhalation) is appropriate for the medication formulation and the clinical condition of the patient.
• Confirm enteral vs parenteral appropriateness: never administer an oral liquid via an IV line (use dedicated purple ENFit enteral syringes for all tube flushes and liquid medications to prevent fatal route misconnections).

5. Right Time & Frequency

• Administer medications within the hospital's approved administration window (typically within 30 minutes before or after the scheduled time).
• Align administration with physiological meals (e.g., rapid-acting insulin given with or immediately after food; omeprazole given 30 to 60 minutes prior to breakfast; phosphate binders taken with meals).
• Maintain therapeutic antimicrobial intervals (e.g., TDS = every 8 hours; QDS = every 6 hours) to prevent trough levels from falling below minimum inhibitory concentrations.

6. Right Reason / Indication

• The nurse must understand the clinical indication for every administered drug. If a patient is prescribed an antihypertensive, the nurse must check the baseline blood pressure; if prescribed digoxin, the nurse must confirm that the apical heart rate is ≥ 60 bpm.
• If the clinical rationale is absent, ambiguous, or contraindicated by current patient assessment findings, the nurse is professionally obligated to withhold the medication and consult the prescriber.

7. Right Documentation

• Document immediately after administration: Sign the medication kardex directly after the patient swallows the tablet or the injection is completed. Never sign the kardex before administration, and never sign for doses administered by another professional.
• If a dose is withheld or refused, record the appropriate standardized omission code immediately in the kardex slot and provide full narrative documentation in the nursing notes.

8. Right to Refuse

• Adult patients with decision-making capacity have the legal and ethical right to refuse any treatment or medication under the Assisted Decision-Making (Capacity) Act 2015.
• When a patient refuses:
  1. Do not argue, coerce, or deceive the patient (never hide medications in food or drinks; covert administration is illegal unless sanctioned under strict multidisciplinary capacity protocols).
  2. Explore the patient's reasons for refusal (e.g., unpleasant taste, fear of side effects, nausea).
  3. Provide balanced education regarding the potential clinical risks of skipping the dose.
  4. If refusal persists, document the refusal using the standardized omission code on the kardex, notify the medical team or prescriber, and document the discussion in the healthcare record.

9. Right Patient Education

• Inform the patient about the generic name, purpose, expected therapeutic actions, and potential common side effects of their medications.
• Instruct the patient on warning signs that demand immediate notification (e.g., notifying the nurse immediately of rash, swelling, or dizziness after an antibiotic).

10. Right Evaluation / Response

• Systematically assess the patient's clinical response following administration.
• Evaluate objective and subjective parameters: monitor pain score reduction 30 minutes after analgesia, track INEWS physiological parameters, monitor blood glucose following insulin, and document any adverse drug reactions.

Prescription Validation & The Medication Kardex in Irish Practice

The hospital Medication Kardex (Medication Administration Record - MAR) is the official clinical and legal instrument authorizing medication administration in Irish acute facilities.

Statutory Legal Requirements of a Valid Prescription

Under the Irish Medicinal Products (Prescription and Control of Supply) Regulations, a nurse can only administer a prescription-only medicine upon presentation of a valid, authentic order. A complete hospital prescription must clearly include:

1. Patient Demographics: Full legal name, date of birth, hospital Medical Record Number (MRN), ward name, and admitting consultant.
2. Allergy & ADR Documentation: The allergy status box must be completed, signed, and dated by the medical officer. If the patient has no known allergies, it must clearly state 'No Known Drug Allergies' (NKDA). If allergies exist, the offending agent, specific reaction (e.g., anaphylaxis vs mild rash), and date must be recorded. A nurse must never administer a drug if the allergy section is blank!
3. Drug Details: The non-proprietary (generic) chemical name written legibly in ink (or printed in an electronic prescribing system).
4. Dosage: Specified in standard metric units (e.g., grams, milligrams, micrograms). Safe notation rules must be observed:
   • Leading Zeros: Must always precede a decimal (e.g., write 0.5 mg, never .5 mg).
   • No Trailing Zeros: Trailing zeros are strictly forbidden (e.g., write 5 mg, never 5.0 mg).
   • Spell Out Units: 'Units' must be written in full (never 'U').
5. Route of Administration: Unambiguously stated (e.g., Oral, IV, SC, IM, PR, Inh).
6. Frequency and Specific Administration Times: Specific times must be indicated on the kardex grid (e.g., 08:00, 14:00, 20:00).
7. Prescriber Authentication: The legible handwritten signature of the registered medical practitioner, dentist, or registered nurse prescriber (RNP), accompanied by their Medical Council Registration Number (MCRN) or NMBI PIN, and the prescription date.

[!CAUTION] Verbal and Telephone Orders in Irish Practice: NMBI guidelines state that verbal or telephone medication orders are strictly prohibited in routine nursing practice due to high error rates. A telephone order is only permissible in a genuine, life-threatening clinical emergency where the prescriber is physically absent. In such circumstances:

1. The order must be received by a Registered Nurse and independently witnessed/listened to by a second Registered Nurse.
2. The order must be read back in full (drug, dose, route, frequency) and explicitly confirmed by the prescriber.
3. Both nurses must sign the emergency order entry on the kardex.
4. The prescriber is legally required to physically review, countersign, and date the kardex within 24 hours.

Withholding Medications & Standard National Omission Codes

When a scheduled medication cannot or should not be administered, the nurse must never leave the signature box blank. Leaving an empty space compromises the audit trail and invites duplicate dosing. The nurse must record the appropriate standardized national omission code inside the administration slot and initial it:

Standard National Medication Kardex Omission Codes

---

Crushing Tablets & Enteral Administration Prohibitions

Crushing tablets or opening capsules constitutes an unlicensed alteration of a medicinal product. When a nurse alters a solid dosage form without manufacturer authorization, the medicine falls outside its marketing authorization (licence), shifting legal liability for any adverse pharmacokinetic outcome directly onto the healthcare professional.

+-----------------------------------------------------------------------------+
|                      THE 'NEVER CRUSH' MEDICATION MATRIX                    |
+-----------------------------------------------------------------------------+
| 1. MODIFIED-RELEASE / EXTENDED-RELEASE (MR, SR, CR, XL, LA, ER):            |
|    - Designed to release drug gradually over 12 to 24 hours.                |
|    - Crushing causes 'DOSE DUMPING': entire 24-hour dose absorbed instantly!|
|    - Examples: OxyContin (oxycodone MR), MST Continus, Adalat LA, Verapamil |
|    - OUTCOME: Fatal overdose, acute toxicity, profound hypotension/apnoea.  |
|                                                                             |
| 2. ENTERIC-COATED FORMULATIONS (EC, EN):                                    |
|    - Acid-resistant coating prevents dissolution in acidic stomach pH.      |
|    - Purpose: Protects stomach lining from ulceration OR protects acid-     |
|      labile drug from gastric degradation before reaching the duodenum.     |
|    - Examples: Omeprazole, Enteric-coated Aspirin (Nu-Seals), Sulfasalazine |
|    - OUTCOME: Drug destroyed by stomach acid (therapeutic failure) or severe|
|      gastric mucosal ulceration.                                            |
|                                                                             |
| 3. SUBLINGUAL & BUCCAL MEDICATIONS:                                         |
|    - Formulated for rapid transmucosal absorption directly into systemic    |
|      veins, bypassing extensive hepatic first-pass metabolism.              |
|    - Examples: Glyceryl Trinitrate (GTN) sublingual, Temgesic (buprenorphine)|
|    - OUTCOME: Complete hepatic degradation if swallowed; therapeutic failure|
|                                                                             |
| 4. CYTOTOXIC, TERATOGENIC & HORMONAL FORMULATIONS:                          |
|    - Examples: Methotrexate, Finasteride, Tamoxifen, Mycophenolate          |
|    - OUTCOME: Airborne aerosolization of powder exposing nursing staff and  |
|      patients to occupational mutagenic/teratogenic risks.                  |
+-----------------------------------------------------------------------------+

Clinical Alternatives for Dysphagic or Enteral Tube Patients

1. Consult the clinical ward pharmacist to identify licensed alternative formulations (oral solutions, suspensions, effervescent tablets, or transdermal patches).
2. Check whether the tablet is an authorized dispersible formulation (e.g., Omeprazole MUPS [Multiple Unit Pellet System] tablets can be dispersed in water, but the tiny pellets must NEVER be crushed because each pellet has its own microscopic enteric coating).
3. If no licensed alternative exists, request the prescriber to prescribe a licensed liquid or approve an off-label liquid preparation with formal multidisciplinary documentation.

Misuse of Drugs Regulations (Ireland) 1988/2017 & Controlled Drugs

In the Republic of Ireland, medications with high liability for abuse, dependence, and illicit diversion are regulated under the Misuse of Drugs Acts (1977 to 2016) and the Misuse of Drugs Regulations 2017.

Controlled Drug Schedules Relevant to Irish Hospital Nursing

• Schedule 1 (CD1): Substances with no recognized therapeutic medical use (e.g., raw opium, cannabis resin, illicit hallucinogens). Production and possession prohibited except under special ministerial licence.
• Schedule 2 (CD2): Potent opioids and stimulants with major therapeutic value but high abuse potential:
  • Examples: Morphine, Diamorphine, Oxycodone, Fentanyl, Alfentanil, Remifentanil, Pethidine, Methadone, Hydromorphone, Cocaine, Methylphenidate, Dexamfetamine.
  • Statutory Requirements: Subject to full safe custody requirements (locked cupboard), mandatory registration of every dose in the Controlled Drugs Register, strict prescription validity rules, and witnessed destruction.
• Schedule 3 (CD3): Minor stimulants, certain barbiturates, and potent benzodiazepine-like drugs:
  • Examples: Buprenorphine, Temazepam, Flunitrazepam, Midazolam, Tramadol (tramadol placed under CD3 schedule in Ireland in 2017).
  • Statutory Requirements: Subject to safe custody storage requirements. Midazolam and Temazepam are stored in the locked Controlled Drugs Cupboard. In most Irish hospitals, CD register recording is required by local policy for Buprenorphine and Temazepam.
• Schedule 4 (CD4): Benzodiazepines (e.g., Diazepam, Lorazepam, Clonazepam, Chlordiazepoxide) and 'Z-drugs' (Zopiclone, Zolpidem). Stored in standard locked medicine cupboards; register recording not statutorily mandated.
• Schedule 5 (CD5): Low-strength preparations of certain controlled drugs (e.g., Codeine phosphate < 100 mg, Co-codamol, Pholcodine). Exempt from safe custody and register recording.

Safe Custody & Key Security Protocols

• Storage Specification: Schedule 2 and Schedule 3 Controlled Drugs must be kept in a robust metal Controlled Drugs Cupboard fitted with a double-locking mechanism or two separate key-operated locks. The cupboard must be permanently bolted to a solid masonry wall or concrete floor.
• Key Custody: The keys to the Controlled Drugs Cupboard must remain on the physical person of the Registered General Nurse (RGN) in charge of the ward (Clinical Nurse Manager or designated senior staff nurse) at all times during the shift.
  • The CD keys must never be left unattended on a desk, hooked on a wall, or placed in an open drawer.
  • The CD keys must never be handed over to unauthorized personnel, students, agency healthcare assistants, or medical interns.
  • The keys may only be transferred between registered nurses during a formal, face-to-face handover.

The Controlled Drug Register (CD Register) & Documentation Protocols

The Controlled Drug Register is an official legal document subject to inspection by the Health Products Regulatory Authority (HPRA), NMBI, and An Garda Síochána.

+-----------------------------------------------------------------------------+
|                   CONTROLLED DRUGS REGISTER LEGAL STANDARDS                 |
+-----------------------------------------------------------------------------+
| - Must be a BOUND BOOK with consecutively PRE-NUMBERED PAGES.               |
| - A SEPARATE FOLIO (PAGE) must be dedicated to each specific drug,          |
|   formulation, and strength (e.g., Morphine Sulfate 10 mg/mL has a separate |
|   page from Morphine Sulfate 20 mg/mL).                                     |
| - Running balance tally must be calculated and entered after EVERY single   |
|   transaction.                                                              |
| - ENTRIES MUST BE INDELIBLE (written in ink, never pencil).                 |
| - NO WHITE-OUT / TIPP-EX / CORRECTION FLUID IS PERMITTED UNDER ANY          |
|   CIRCUMSTANCES!                                                            |
| - If an error occurs: Draw a single horizontal line through the error,      |
|   initial it, date it, and write the correction clearly. The original       |
|   incorrect entry must remain legible.                                      |
| - Register must be retained on the ward for a MINIMUM OF TWO YEARS from the |
|   date of the last entry.                                                   |
+-----------------------------------------------------------------------------+

Mandatory Two-Nurse Independent Verification

Every administration of a Schedule 2 (and hospital-designated Schedule 3) Controlled Drug requires two registered nurses (or one registered nurse and a registered medical practitioner) to independently verify the following at every step:

1. Prescription Check: Verify that the drug, dose, route, and time are legally valid and due.
2. Cupboard Retrieval: Open the CD cupboard; locate the exact drug, formulation, and strength.
3. Stock Audit: Confirm that the physical count of ampoules/tablets in the box matches the running balance in the CD register.
4. Preparation & Dose Calculation: Both nurses witness the opening of the ampoule, draw up the volume, check the syringe graduations, and discard remaining partial doses.
5. Bedside Patient Identification: Both nurses go to the bedside, confirm the patient's identity using three identifiers (verbal name and DOB, wristband, and kardex), check allergies, and witness administration.
6. Register & Kardex Signing: Both nurses immediately sign the CD register (date, time, patient name, dose administered, dose discarded, signatures of administering nurse and witnessing nurse, and new stock balance) and countersign the medication kardex.

Disposal of Controlled Drugs & Handover Audits

• Wastage of Partial Doses: When a patient receives only part of an ampoule (e.g., prescribed 5 mg Morphine Sulfate from a 10 mg/1 mL ampoule):
  • The remaining 5 mg (0.5 mL) must be rendered unrecoverable by discarding it into a hospital-approved chemical denaturing kit (or absorbed onto clinical waste per local SOP).
  • The destruction must be witnessed and signed by both registered nurses in the CD register.
  • Never store a partially used ampoule for later administration!
• Shift-to-Shift Stock Handover Check:
  • At every formal shift change (e.g., morning to afternoon, day to night shift), two registered nurses—one from the outgoing shift and one from the incoming shift—must conduct a joint physical stock count.
  • Every single tablet, ampoule, and transdermal patch in the CD cupboard must be physically counted and reconciled against the running balance in the CD register.
  • Both nurses sign the register verifying that all balances are correct and keys are transferred.

Medication Incidents, Near Misses & Open Disclosure

Medication errors can occur at any phase of the medication process: prescribing, transcribing, dispensing, administering, or monitoring. The Irish health system operates within a 'Just Culture' paradigm, which balances individual professional accountability with an understanding of systemic and human factors.

+-----------------------------------------------------------------------------+
|               IMMEDIATE RESPONSE TO A MEDICATION ADMINISTRATION ERROR       |
+-----------------------------------------------------------------------------+
| 1. IMMEDIATE PATIENT ASSESSMENT (Priority 1):                               |
|    - Assess Airway, Breathing, Circulation, Disability (ABCDE approach).    |
|    - Record complete vital signs and calculate Irish National Early Warning |
|      Score (INEWS).                                                         |
|    - Institute emergency stabilization: administer reversal agents if       |
|      indicated (Naloxone for opioids, Flumazenil for benzodiazepines).      |
|                                                                             |
| 2. IMMEDIATE MEDICAL NOTIFICATION:                                          |
|    - Alert the treating medical team / on-call doctor immediately.          |
|    - Notify the Clinical Nurse Manager (CNM) and clinical ward pharmacist.  |
|                                                                             |
| 3. OPEN DISCLOSURE:                                                         |
|    - In accordance with the HSE Open Disclosure Policy and the Civil        |
|      Liability (Amendment) Act 2017, provide a timely, compassionate,       |
|      and honest explanation of what occurred to the patient and/or family.  |
|                                                                             |
| 4. INCIDENT REPORTING & SYSTEM LEARNING:                                     |
|    - Complete an incident report on the National Incident Management System |
|      (NIMS) within 24 hours.                                                |
|    - Document objective clinical facts, observations, and treatments in the |
|      healthcare record. (Never write 'incident form completed' in notes).   |
|    - Participate in root-cause analysis (RCA) to rectify system flaws.      |
+-----------------------------------------------------------------------------+

[!IMPORTANT] Near Miss Reporting: A Near Miss is an incident that had the potential to cause patient harm, but was intercepted or prevented prior to reaching the patient (e.g., a nurse notices that pharmacy supplied gliclazide 80 mg instead of gliclazide 30 mg MR, and catches the discrepancy before administration). Near misses must be reported via NIMS with the same diligence as actual errors, providing valuable intelligence on system vulnerabilities.